The SUMO E3 ligase CBX4 is identified as a poor prognostic marker of gastric cancer through multipronged OMIC analyses

The SUMO E3 ligase CBX4 is identified as a poor prognostic marker of gastric cancer through multipronged OMIC analyses

Gastric cancer (GC) is one of the most common malignancies, with an ever-increasing incidence and high mortality rate. Chromobox4 (CBX4), also named hPC2, is a small ubiquitin-related modifier (SUMO) E3 ligase. Previous studies have found that high CBX4 expression is associated with tumor size, path...

Full description

Bibliographic Details
Main Authors: Yi Pan, Qingshang Li, Zhijun Cao, Shuliang Zhao
Format: Article
Language:English
Published: KeAi Communications Co., Ltd. 2021-11-01
Series:Genes and Diseases
Subjects:
Bioinformatics analysis
Chromobox4 (CBX4)
Gastric cancer
Prognostic biomarker
Therapeutic target
Online Access:http://www.sciencedirect.com/science/article/pii/S235230422030115X

Internet

http://www.sciencedirect.com/science/article/pii/S235230422030115X

Similar Items